Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-241706
Filing Date
2017-07-31
Accepted
2017-07-31 10:13:51
Documents
33
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d313404d10q.htm 10-Q 164728
2 EX-31.1 d313404dex311.htm EX-31.1 6423
3 EX-31.2 d313404dex312.htm EX-31.2 6426
4 EX-32.1 d313404dex321.htm EX-32.1 2942
5 EX-32.2 d313404dex322.htm EX-32.2 2873
  Complete submission text file 0001193125-17-241706.txt   977624

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20170630.xml EX-101.INS 95466
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20170630.xsd EX-101.SCH 15241
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20170630_cal.xml EX-101.CAL 22076
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20170630_def.xml EX-101.DEF 42681
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20170630_lab.xml EX-101.LAB 121346
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20170630_pre.xml EX-101.PRE 80614
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 17991838
SIC: 8731 Services-Commercial Physical & Biological Research